MetLife Investment Management LLC Takes $212,000 Position in Bicara Therapeutics Inc. (NASDAQ:BCAX)
MetLife Investment Management LLC bought a new position in shares of Bicara Therapeutics Inc. (NASDAQ:BCAX – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 12,163 shares of the company’s stock, valued at approximately $212,000. Other institutional investors and hedge funds have […]
